BILL ANALYSIS

HR7945

NEUTRAL

To ban the sale of nitrous oxide consumer products, and for other purposes.

HR7945 (To ban the sale of nitrous oxide consumer products, and for other purposes.) has been assessed with a neutral outlook for investors. This legislation directly affects General Mills ($GIS), Kraft Heinz ($KHC), Coca-Cola ($KO) and Mondelez ($MDLZ) and 2 other tickers. The primary sectors impacted are Consumer and Manufacturing. View the full bill text on Congress.gov.

neutral

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

HR7945 exempts all food products using N2O as a propellant — major food/beverage stocks are unaffected

The bill targets recreational nitrous oxide products, a market with no material publicly traded US exposure

Zero legislative momentum since March 16 — single sponsor, one cosponsor, no committee action

How HR7945 Affects the Market

No actionable market implications. The bill's exemptions effectively neuter any impact on $KHC, $PEP, $KO, $MDLZ, $SJM, $GIS, or any other publicly traded consumer staples company. The recreational nitrous oxide market is dominated by small non-traded entities. Stock movements for these tickers over the past 30 days ($KO +3.39%, $MDLZ +6.35%, $GIS -7.04%) reflect earnings and macro factors, not legislative risk. Investors should ignore this bill for portfolio allocation purposes.

Bill Details

Metric	Value
Bill Number	HR7945
Market Sentiment	neutral
Event Date	March 16, 2026
Affected Sectors	Consumer, Manufacturing
Affected Stocks	General Mills ($GIS), Kraft Heinz ($KHC), Coca-Cola ($KO), Mondelez ($MDLZ), PepsiCo ($PEP), $SJM
Source	View on Congress.gov →

Summary

HR7945, the Nitrous Oxide Safety Act of 2026, is an early-stage bill referred to the House Energy and Commerce Committee. It would ban consumer products containing nitrous oxide but carves out broad exemptions for medical/dental use, commercial food production, and food products using N2O as a propellant — meaning no impact on major food/beverage companies. The bill has only one sponsor (a junior member) and one cosponsor, with no further legislative action since introduction. Market data shows no bill-related price movements.

Full AI Market Analysis

HR7945 was introduced on March 16, 2026 by Rep. Kevin Mullin (D-CA-15) and referred to the House Committee on Energy and Commerce. The bill would classify any consumer product containing nitrous oxide as a banned hazardous product under the Consumer Product Safety Act, effective 180 days after enactment. However, Section 2(b) explicitly exempts N2O used in medical/dental treatment, commercial food production, commercial kitchens, and any consumer food product where N2O is used as a propellant to drive food out of a pressurized container. This last exemption covers virtually all consumer food aerosol products (whipped cream dispensers, cooking sprays, etc.). No funding is authorized or appropriated by this bill — it is purely a product safety regulation. Because of the broad food propellant exemption, major food and beverage companies like Kraft Heinz ($KHC), PepsiCo ($PEP), Coca-Cola ($KO), Mondelez ($MDLZ), J.M. Smucker ($SJM), and General Mills ($GIS) face zero structural impact. The bill targets recreational N2O products (e.g., 'whippits' sold for recreational inhalation), not food-grade products. No publicly traded US companies have material revenue exposure to standalone recreational nitrous oxide consumer products; these are primarily sold by small specialty retailers and importers. Real market data shows $KHC at $22.46 (30-day change -0.13%), $PEP at $156.57 (+0.82%), $KO at $78.63 (+3.39%), $MDLZ at $61.30 (+6.35%), $SJM at $97.28 (+0.87%), and $GIS at $34.60 (-7.04%). These movements are consistent with sector-wide trends and earnings narratives — there is no evidence of any bill-related volatility. The bill has seen zero legislative action since referral, has only two sponsors total, and has not been scheduled for committee markup. Remaining legislative path: The bill must pass through the Energy and Commerce Committee, then the full House, then the Senate, and be signed by the President. With committee assignment to a low-priority docket and minimal bipartisan support, the probability of enactment in the 119th Congress is negligible. No companion Senate bill exists.